IP Library Assignment 031864/0556
Patent Assignment
Reel/Frame 031864/0556

Merger

Recorded: 2013-12-31 Pages: 9
Assignors
APEX MERGER SUB, INC.
Executed: 2009-04-17
CV THERAPEUTICS, INC.
Executed: 2009-04-17
Assignee
GILEAD PALO ALTO, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Properties (13)
Use of Sulfated Polysaccharides to Inhibit Pancreatic Cholesterol Esterase
Patent: 5,017,565 →
Application: 07/340,868 →
Use of Sulfated Polysaccharides to Decrease Cholesterol and Fatty Acid Absorption
Patent: 5,063,210 →
Application: 07/429,398 →
Method for Measuring Human Cholesterol Absorption Using Metabolically Stable Isotopes
Patent: 5,432,058 →
Application: 07/954,864 →
Pancreatic Cholesterol Esterase Inhibitor
Patent: 5,484,777 →
Application: 08/167,725 →
Use of Non-Absorbable Synthetic Sulfated Polysaccharides to Decrease Cholesterol Absorbtion
Patent: 5,616,570 →
Application: 08/283,723 →
Method of Manufacturing Non-Absorbable Synthetic Sulfated Polysaccharides
Patent: 5,521,303 →
Application: 08/322,782 →
Peptides from Mammalian Pancreatic Cholesterol Esterase
Patent: 5,792,832 →
Application: 08/461,881 →
Kidney Na/PO4 Cotransporter Antisense Oligonucleotide
Patent: 5,840,875 →
Application: 08/467,007 →
Method of Treating Ulcers with Sulfated Polysaccharides
Patent: 5,679,375 →
Application: 08/481,751 →
Substituted Piperazine Compounds
Patent: 6,677,343 →
Application: 09/791,262 →
Publication: US 2001/0044541
Method of Preventing Reperfusion Injury
Patent: 6,599,283 →
Application: 09/848,809 →
Substituted Pyrrolo[3,2-D]Pyrimidin-2,4-Diones as A2B Adenosine Receptor Antagonists
Patent: 7,449,473 →
Application: 10/973,167 →
Publication: US 2005/0119287
Substituted Bicyclic and Tricyclic Thieno [2,3-d]pyrmadines as A2A Adenosine Receptor Antagonists
Application: 11/681,378 →
Publication: US 2007/0208040
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Oct 4, 1996
From: CV THERAPEUTICS, INC.
To: HAMBRECHT & QUIST GUARANTY FINANCE, LLC
Reel/Frame 008133/0190 →
Security Agreement Oct 8, 1996
From: CV THERAPEUTICS, INC.
To: HAMBRECHT & QUIST TRANSITION CAPITAL, LLC
Reel/Frame 008167/0271 →
Assignment of Assignor's Interest Oct 18, 2001
From: MARZILLI, MARIO; BLACKBURN, BRENT
To: CV THERAPEUTICS, INC.
Reel/Frame 012285/0096 →
Assignment of Assignor's Interest Feb 1, 2005
From: KALLA, RAO; ELZEIN, ELFATIH; MARQUET, TIM; PERRY, THAO
To: CV THERAPEUTICS, INC.
Reel/Frame 015644/0492 →
Termination of Security Agreement Mar 24, 2005
From: HAMBRECHT & QUIST GUARANTY FINANCE, LLC
To: CV THERAPEUTICS, INC.
Reel/Frame 015953/0657 →
Termination of Security Agreement Mar 24, 2005
From: HAMBRECHT & QUIST TRANSITION CAPITAL, LLC
To: CV THERAPEUTICS, INC.
Reel/Frame 015953/0634 →
Assignment of Assignor's Interest Jun 25, 2008
From: ELZEIN, ELFATIH; KALLA, RAO; ZABLOCKI, JEFF; LI, XIAOFEN
To: CV THERAPEUTICS, INC.
Reel/Frame 021151/0568 →
Assignment of Assignor's Interest Dec 31, 2013
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 031864/0586 →